81420-2

LOINC 2.82

KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

KRAS + NRAS Mut Anl Bld/T

Definition

  • This assay will detect mutations in exons 2, 3 and 4 of both the KRAS and NRAS genes, allowing the determination of drug response. This term was created for, but not limited in use to, the ABI PRISM SNaPshot Multiplex Kit.

Component

  • KRAS & NRAS gene targeted mutation analysis

Specimen / system

  • Bld/Tiss

Class

  • MOLPATH.MUT

Property

  • Prid

Scale

  • Nom

Method

  • Molgen

Related names

  • ALPS4; Blood; CMNS; Genetics; Heredity; Heritable; Identity or presence; Inherited; KRAS + NRAS; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NCMS; neuroblastoma RAS viral (v-ras) oncogene homolog; Nominal; N-ras; NRAS1; NS6; Oncogene NRAS; PCR; Point in time; Random; Tissue; Tissue, unspecified; v-ras neuroblastoma RAS viral oncogene homolog; WB; Whole blood; Whole blood or Tissue

Index terms

  • ALPS4
  • Blood
  • CMNS
  • Genetics
  • Heredity
  • Heritable
  • Identity or presence
  • Inherited
  • KRAS & NRAS gene targeted mutation analysis
  • KRAS + NRAS
  • Molecular genetics
  • Molecular pathology
  • MOLPATH
  • MOLPATH.MUTATIONS
  • Mut
  • Mut Anl
  • Mutations
  • N-ras
  • NCMS
  • neuroblastoma RAS viral (v-ras) oncogene homolog
  • Nominal
  • NRAS1
  • NS6
  • Oncogene NRAS
  • PCR
  • Point in time
  • Random
  • Tissue
  • Tissue, unspecified
  • v-ras neuroblastoma RAS viral oncogene homolog
  • WB
  • Whole blood
  • Whole blood or Tissue